A Case Report of Managing Cognitive Impairment in an Older Adult Patient Using Benzodiazepines and Antidepressants
Abstract
Background: Benzodiazepines (BZDs) are commonly prescribed for treating insomnia in Taiwan. BZDs may cause reversible cognitive impairment such as amnesia, which can mimic dementia and complicate diagnosis. Case Report: We described an 84-year-old Taiwanese married female patient with major depressive disorder, generalized anxiety disorder, and severe cognitive impairment after received a two-year course of escitalopram, oxazepam, and brotizolam. Initially, she showed remarkable deficits in recent memory, similarity tests, and proverb interpretation. After a structured schedule of titrating mirtazapine and augmenting venlafaxine as well as deprescribing BZDs, her depressive symptoms and cognition were improved steadily. By day 29, her characteristic sense of humor returned, reflecting both symptomatic recovery and return of her normal self. Conclusion: This case highlights the importance of treating underlying diseases maximally to improve sleeping difficulties and deprescribe unneeded BZDs. Careful medication review and deprescribing BZDs can prevent misdiagnosis and ensure patient’s recovery.
Related
- Extracellular vesicles in vascular cognitive impairment and dementia: a neurovascular evidence map for patient stratification and clinical translation
- Psychometric Properties of Patient-Reported Outcome Measures for Cancer-Related Cognitive Impairment: A Systematic Review.
- Beyond sedation: a narrative review of nonpharmacological innovations for managing patient anxiety in magnetic resonance imaging examinations Além da sedação: inovações não farmacológicas para o manejo da ansiedade em exames de ressonância magnética, uma revisão narrativa
- The Role of Community Pharmacists in Identifying and Managing Insomnia and Facilitating Access to Cognitive Behavioural Therapy for Insomnia (CBT-I) – a Systematic Review
- CSF APOE Secondary Glycosylation Predicts Cognitive Decline in Mild Cognitive Impairment
BibTeX
@article{zhlinli2026case,
title = {{A Case Report of Managing Cognitive Impairment in an Older Adult Patient Using Benzodiazepines and Antidepressants}},
author = {Zh-Lin Li, M.D. and I-Han Lee, M.D. and Winston W. Shen, M.D.},
journal = {Taiwanese Journal of Psychiatry},
year = {2026},
month = jul,
doi = {10.4103/tpsy.tpsy_31_26},
url = {https://doi.org/10.4103/tpsy.tpsy_31_26},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - A Case Report of Managing Cognitive Impairment in an Older Adult Patient Using Benzodiazepines and Antidepressants
AU - Zh-Lin Li, M.D.
AU - I-Han Lee, M.D.
AU - Winston W. Shen, M.D.
PY - 2026
DA - 2026/07/01
JO - Taiwanese Journal of Psychiatry
DO - 10.4103/tpsy.tpsy_31_26
UR - https://doi.org/10.4103/tpsy.tpsy_31_26
AB - Background: Benzodiazepines (BZDs) are commonly prescribed for treating insomnia in Taiwan. BZDs may cause reversible cognitive impairment such as amnesia, which can mimic dementia and complicate diagnosis. Case Report: We described an 84-year-old Taiwanese married female patient with major depressive disorder, generalized anxiety disorder, and severe cognitive impairment after received a two-year course of escitalopram, oxazepam, and brotizolam. Initially, she showed remarkable deficits in recent memory, similarity tests, and proverb interpretation. After a structured schedule of titrating mirtazapine and augmenting venlafaxine as well as deprescribing BZDs, her depressive symptoms and cognition were improved steadily. By day 29, her characteristic sense of humor returned, reflecting both symptomatic recovery and return of her normal self. Conclusion: This case highlights the importance of treating underlying diseases maximally to improve sleeping difficulties and deprescribe unneeded BZDs. Careful medication review and deprescribing BZDs can prevent misdiagnosis and ensure patient’s recovery.
SN - 1028-3684
SN - 2666-2078
ER -